![Diane Mellett](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Diane Mellett
Directeur/Membre du Conseil chez
CIRCIO HOLDING ASA
Profil
Ms. Diane Mellett is an Independent Director at Circio Holding ASA. She is on the Board of Directors at Circio Holding ASA. Ms. Mellett was previously employed as a Chief Business Officer & General Counsel by Affitech A/S and a General Counsel by Cambridge Antibody Technology Ltd. She also served on the board at BioXpress Therapeutics SA.
Postes actifs de Diane Mellett
| Sociétés | Poste | Début |
|---|---|---|
| CIRCIO HOLDING ASA | Directeur/Membre du Conseil | 14/09/2015 |
Anciens postes connus de Diane Mellett
| Sociétés | Poste | Fin |
|---|---|---|
MedImmune Ltd.
 MedImmune Ltd. BiotechnologyHealth Technology Engages in research and development of human monoclonal antibodies | Conseiller Juridique Général | 30/06/2006 |
BioXpress Therapeutics SA
 BioXpress Therapeutics SA BiotechnologyHealth Technology Provides biosimilar biologic APIs for unmet need indications such as cancer, inflammation and autoimmunity | Directeur/Membre du Conseil | - |
Affitech A/S
 Affitech A/S Pharmaceuticals: MajorHealth Technology Researches and develops human antibody therapeutics | Directeur/Membre du Conseil | 27/05/2010 |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
25
Relations au 1er degré
4
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
MedImmune Ltd.
MedImmune Ltd. BiotechnologyHealth Technology Engages in research and development of human monoclonal antibodies | Health Technology |
Affitech A/S
Affitech A/S Pharmaceuticals: MajorHealth Technology Researches and develops human antibody therapeutics | Health Technology |
Circio Holding ASA
 Circio Holding ASA BiotechnologyHealth Technology Develops active immunotherapy cancer vaccines | Health Technology |
BioXpress Therapeutics SA
BioXpress Therapeutics SA BiotechnologyHealth Technology Provides biosimilar biologic APIs for unmet need indications such as cancer, inflammation and autoimmunity | Health Technology |
